MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present a company overview at the following investor conferences:
- Stifel 2018 Healthcare Conference in New York at 2:00 p.m. ET on Wednesday, November 14, 2018
- 30th Annual Piper Jaffray Healthcare Conference in New York at 11:30 a.m. ET on Tuesday, November 27, 2018
A live audio webcast of each presentation will be available on Geron’s website, www.geron.com/investors/events. If you are unable to listen to the live presentations, an archived webcast of each presentation will be available on the Company’s website for 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT:
Suzanne Messere
Investor and Media Relations
investor@geron.com
media@geron.com
CG Capital
877-889-1972